Meng, Fan-Yi’s team published research in Nature Communications in 2022 | CAS: 589-87-7

1-Bromo-4-iodobenzene(cas: 589-87-7) is mainly used as the OLED pharmaceutical intermediate, as reagent for in situ desilylation and coupling of silylated alkynes, as substrate in copper-free Sonogashira coupling in aqueous acetone..SDS of cas: 589-87-7 It is also used in synthesis of β,β,dibromostyrenes, as starting reagent in the total syntheses of ent-conduramine A and ent-7-deoxypancratistatin (alkaloids)

In 2022,Meng, Fan-Yi; Chen, I-Han; Shen, Jiun-Yi; Chang, Kai-Hsin; Chou, Tai-Che; Chen, Yi-An; Chen, Yi-Ting; Chen, Chi-Lin; Chou, Pi-Tai published an article in Nature Communications. The title of the article was 《A new approach exploiting thermally activated delayed fluorescence molecules to optimize solar thermal energy storage》.SDS of cas: 589-87-7 The author mentioned the following in the article:

We propose a new concept exploiting thermally activated delayed fluorescence (TADF) mols. as photosensitizers, storage units and signal transducers to harness solar thermal energy. Mol. composites based on the TADF core phenoxazine-triphenyltriazine (PXZ-TRZ) anchored with norbornadiene (NBD) were synthesized, yielding compounds PZDN and PZTN with two and four NBD units, resp. Upon visible-light excitation, energy transfer to the triplet state of NBD occurred, followed by NBD → quadricyclane (QC) conversion, which can be monitored by changes in steady-state or time-resolved spectra. The small S1-T1 energy gap was found to be advantageous in optimizing the solar excitation wavelength. Upon tuning the mol.′s triplet state energy lower than that of NBD (61 kcal/mol), as achieved by another composite PZQN, the efficiency of the NBD → QC conversion decreased drastically. Upon catalysis, the reverse QC → NBD reaction occurred at room temperature, converting the stored chem. energy back to heat with excellent reversibility. The results came from multiple reactions, including the reaction of 1-Bromo-4-iodobenzene(cas: 589-87-7SDS of cas: 589-87-7)

1-Bromo-4-iodobenzene(cas: 589-87-7) is mainly used as the OLED pharmaceutical intermediate, as reagent for in situ desilylation and coupling of silylated alkynes, as substrate in copper-free Sonogashira coupling in aqueous acetone..SDS of cas: 589-87-7 It is also used in synthesis of β,β,dibromostyrenes, as starting reagent in the total syntheses of ent-conduramine A and ent-7-deoxypancratistatin (alkaloids)

Referemce:
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com